首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
【24h】

Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.

机译:通过流式细胞仪测量循环细胞来源的微粒:分析中变异性的来源。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Circulating cell-derived microparticles (MPs) have been implicated in several disease processes and elevated levels are found in many pathological conditions. The detection and accurate measurement of MPs, although attracting widespread interest, is hampered by a lack of standardisation. The aim of this study was to establish a reliable flow cytometric assay to measure distinct subtypes of MPs in disease and to identify any significant causes of variability in MP quantification. MATERIALS AND METHODS: Circulating MPs within plasma were identified by their phenotype (platelet, endothelial, leukocyte and annexin-V positivity (AnnV+). The influence of key variables (i.e. time between venepuncture and centrifugation, washing steps, the number of centrifugation steps, freezing/long-term storage and temperature of thawing) on MP measurement were investigated. RESULTS: Increasing time between venepuncture and centrifugation leads to increased MP levels. Washing samples results in decreased AnnV+MPs (P=0.002) and platelet-derived MPs (PMPs) (P=0.002). Double centrifugation of MPs prior to freezing decreases numbers of AnnV+MPs (P=0.0004) and PMPs (P=0.0004). A single freeze thaw cycle of samples led to an increase in AnnV+MPs (P=0.0020) and PMPs (P=0.0039). Long-term storage of MP samples at -80 degrees resulted in decreased MP levels. CONCLUSIONS: This study found that minor protocol changes significantly affected MP levels. This is one of the first studies attempting to standardise a method for obtaining and measuring circulating MPs. Standardisation will be essential for successful development of MP technologies, allowing direct comparison of results between studies and leading to a greater understanding of MPs in disease.
机译:引言:循环细胞来源的微粒(MPs)已牵涉到多种疾病过程中,并且在许多病理状况下均发现其水平升高。 MP的检测和准确测量尽管引起了广泛的关注,但由于缺乏标准化而受到阻碍。这项研究的目的是建立一种可靠的流式细胞仪检测方法,以测量疾病中MP的不同亚型,并确定MP定量变异的任何重要原因。材料与方法:根据血浆中循环MPs的表型(血小板,内皮细胞,白细胞和膜联蛋白-V阳性(AnnV +))进行鉴定,关键变量(如静脉穿刺和离心之间的时间,洗涤步骤,离心步骤的数量,结果:静脉穿刺和离心之间的时间增加导致MP含量增加;洗涤样品导致AnnV + MPs(P = 0.002)和血小板衍生的MPs( PMPs(P = 0.002)。冷冻前对MPs进行两次离心会降低AnnV + MPs(P = 0.0004)和PMPs(P = 0.0004)的数量。样品的单次冻融循环导致AnnV + MPs( P = 0.0020)和PMP(P = 0.0039)。MP样品在-80度下长期保存会导致MP含量降低结论:本研究发现轻微的方案变化会显着影响MP含量,这是首批研究之一。尝试g标准化获取和测量循环MP的方法。标准化对于成功开发MP技术至关重要,它可以直接比较研究之间的结果,并导致对疾病中MP的更多了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号